{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:37:12Z","timestamp":1793979432501,"version":"4.8.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s00228-022-03434-8","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T05:00:21Z","timestamp":1669870821000},"page":"15-38","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Silymarin as a preventive or therapeutic measure for chemotherapy and radiotherapy-induced adverse reactions: a comprehensive review of preclinical and clinical data"],"prefix":"10.1007","volume":"79","author":[{"given":"Mahsa","family":"Ghodousi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedyieh","family":"Karbasforooshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1623-3346","authenticated-orcid":false,"given":"Leila","family":"Arabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9857-1175","authenticated-orcid":false,"given":"Sepideh","family":"Elyasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"3434_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2020.111699","volume":"145","author":"S Akbari","year":"2020","unstructured":"Akbari S, Kariznavi E, Jannati M, Elyasi S, Tayarani-Najaran Z (2020) Curcumin as a preventive or therapeutic measure for chemotherapy and radiotherapy induced adverse reaction: a comprehensive review. Food Chem Toxicol 145:111699","journal-title":"Food Chem Toxicol"},{"issue":"01","key":"3434_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4103\/0971-5851.177015","volume":"37","author":"D Chopra","year":"2016","unstructured":"Chopra D, Rehan H, Sharma V, Mishra R (2016) Chemotherapy-induced adverse drug reactions in oncology patients: a prospective observational survey. Indian Journal of Medical and Paediatric Oncology 37(01):42\u201346","journal-title":"Indian Journal of Medical and Paediatric Oncology"},{"key":"3434_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2019.102831","volume":"145","author":"EY Ibrahim","year":"2020","unstructured":"Ibrahim EY, Ehrlich BE (2020) Prevention of chemotherapy-induced peripheral neuropathy: a review of recent findings. Crit Rev Oncol Hematol 145:102831","journal-title":"Crit Rev Oncol Hematol"},{"key":"3434_CR4","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3389\/fphar.2018.01253","volume":"9","author":"Q-Y Zhang","year":"2018","unstructured":"Zhang Q-Y, Wang F-X, Jia K-K, Kong L-D (2018) Natural product interventions for chemotherapy and radiotherapy-induced side effects. Front Pharmacol 9:1253","journal-title":"Front Pharmacol"},{"key":"3434_CR5","doi-asserted-by":"crossref","unstructured":"Gillessen A, Schmidt HH-J (2020) Silymarin as supportive treatment in liver diseases: a narrative review. Adv Ther 37(4):1279\u2013301","DOI":"10.1007\/s12325-020-01251-y"},{"issue":"9","key":"3434_CR6","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1002\/ptr.5857","volume":"31","author":"S Elyasi","year":"2017","unstructured":"Elyasi S, Shojaee FSR, Allahyari A, Karimi G (2017) Topical silymarin administration for prevention of capecitabine-induced hand\u2013foot syndrome: a randomized, double-blinded, placebo-controlled clinical trial. Phytother Res 31(9):1323\u20131329","journal-title":"Phytother Res"},{"key":"3434_CR7","unstructured":"Yadegari H, Khammari I, Fakheri B, Nouri A, Ebadi T (2021) Flavonolignans of milk thistle (Silybum marianum L.) seeds affected by fertilization type and plant genotype. Int J Horticult Sci Techno 8(4):371\u201384"},{"issue":"16","key":"3434_CR8","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.3390\/molecules27165327","volume":"27","author":"K Wadhwa","year":"2022","unstructured":"Wadhwa K, Pahwa R, Kumar M, Kumar S, Sharma PC, Singh G et al (2022) Mechanistic insights into the pharmacological significance of silymarin. Molecules 27(16):5327","journal-title":"Molecules"},{"key":"3434_CR9","doi-asserted-by":"crossref","unstructured":"Marceddu R, Dinolfo L, Carrubba A, Sarno M, Di Miceli G (2022) Milk thistle (Silybum marianum L.) as a novel multipurpose crop for agriculture in marginal environments: a review. Agronomy 12(3):729","DOI":"10.3390\/agronomy12030729"},{"issue":"9","key":"3434_CR10","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.3390\/molecules25092009","volume":"25","author":"D Delmas","year":"2020","unstructured":"Delmas D, Xiao J, Vejux A, Aires V (2020) Silymarin and cancer: a dual strategy in both in chemoprevention and chemosensitivity. Molecules 25(9):2009","journal-title":"Molecules"},{"issue":"2","key":"3434_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/ptr.6231","volume":"33","author":"H Karbasforooshan","year":"2019","unstructured":"Karbasforooshan H, Hosseini S, Elyasi S, Fani Pakdel A, Karimi G (2019) Topical silymarin administration for prevention of acute radiodermatitis in breast cancer patients: a randomized, double-blind, placebo-controlled clinical trial. Phytother Res 33(2):379\u2013386","journal-title":"Phytother Res"},{"issue":"11","key":"3434_CR12","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3390\/molecules24112155","volume":"24","author":"A Di Costanzo","year":"2019","unstructured":"Di Costanzo A, Angelico R (2019) Formulation strategies for enhancing the bioavailability of silymarin: the state of the art. Molecules 24(11):2155","journal-title":"Molecules"},{"issue":"4","key":"3434_CR13","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1002\/med.21791","volume":"41","author":"V Tvrd\u00fd","year":"2021","unstructured":"Tvrd\u00fd V, Pourov\u00e1 J, Jirkovsk\u00fd E, K\u0159en V, Valentov\u00e1 K, Mlad\u011bnka P (2021) Systematic review of pharmacokinetics and potential pharmacokinetic interactions of flavonolignans from silymarin. Med Res Rev 41(4):2195\u20132246","journal-title":"Med Res Rev"},{"key":"3434_CR14","doi-asserted-by":"crossref","unstructured":"Do\u011fan D, Meydan \u0130, K\u00f6m\u00fcro\u011flu AU (2022) Protective effect of silymarin and gallic acid against cisplatin-induced nephrotoxicity and hepatotoxicity. Int J Clin Pract","DOI":"10.1155\/2022\/6541026"},{"key":"3434_CR15","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.biopha.2018.03.140","volume":"102","author":"A Taleb","year":"2018","unstructured":"Taleb A, Ahmad KA, Ihsan AU, Qu J, Lin N, Hezam K et al (2018) Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases. Biomed Pharmacother 102:689\u2013698","journal-title":"Biomed Pharmacother"},{"key":"3434_CR16","doi-asserted-by":"crossref","unstructured":"Koltai T, Fliegel L (2022) Role of silymarin in cancer treatment: facts, hypotheses, and questions. J Evidence-Based Integrat Med 27:2515690X211068826","DOI":"10.1177\/2515690X211068826"},{"issue":"2","key":"3434_CR17","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.canlet.2008.03.053","volume":"269","author":"K Ramasamy","year":"2008","unstructured":"Ramasamy K, Agarwal R (2008) Multitargeted therapy of cancer by silymarin. Cancer Lett 269(2):352\u2013362","journal-title":"Cancer Lett"},{"key":"3434_CR18","doi-asserted-by":"crossref","unstructured":"Bhagat A, Kleinerman ES (2020) Anthracycline-induced cardiotoxicity: causes, mechanisms, and prevention. Current Advances in Osteosarcoma 181\u201392","DOI":"10.1007\/978-3-030-43032-0_15"},{"key":"3434_CR19","doi-asserted-by":"crossref","unstructured":"Safarpour S, Safarpour S, Moghadamnia AA, Kazemi S, Ebrahimpour A, Shirafkan F et al. (2022) Cardioprotective effect of silymarin nanoemulsion on 5\u2010fluorouracil\u2010induced cardiotoxicity in rats. Archiv der Pharmazie e2200060","DOI":"10.21203\/rs.3.rs-1844264\/v1"},{"issue":"5","key":"3434_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.etp.2017.02.002","volume":"69","author":"H Avci","year":"2017","unstructured":"Avci H, Epikmen ET, \u0130pek E, Tunca R, Birincioglu S, Ak\u015fit H et al (2017) Protective effects of silymarin and curcumin on cyclophosphamide-induced cardiotoxicity. Exp Toxicol Pathol 69(5):317\u2013327","journal-title":"Exp Toxicol Pathol"},{"key":"3434_CR21","doi-asserted-by":"crossref","unstructured":"Chlop\u010d\u00edkov\u00e1 \u0160, Psotov\u00e1 J, Miketov\u00e1 P, \u0160im\u00e1nek V (2004) Chemoprotective effect of plant phenolics against anthracycline\u2010induced toxicity on rat cardiomyocytes. Part I. Silymarin and its flavonolignans. Phytotherapy Research: An Int J Dev Pharmacologic Toxicologic Eval Nat Prod Derivat 18(2):107\u201310","DOI":"10.1002\/ptr.1415"},{"issue":"10","key":"3434_CR22","doi-asserted-by":"publisher","first-page":"8601","DOI":"10.3390\/molecules16108601","volume":"16","author":"A Ra\u0161kovi\u0107","year":"2011","unstructured":"Ra\u0161kovi\u0107 A, Stilinovi\u0107 N, Kolarovi\u0107 J, Vasovi\u0107 V, Vukmirovi\u0107 S, Mikov M (2011) The protective effects of silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats. Molecules 16(10):8601\u20138613","journal-title":"Molecules"},{"key":"3434_CR23","doi-asserted-by":"crossref","unstructured":"Hagag AA, El Shehaby WA, El-Abasy AI, Mabrouk MM (2019) Protective role of silymarin in early doxorubicin-induced cardiac dysfunction in children with acute lymphoblastic leukemia. Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious Disorders) 19(2):133\u201340","DOI":"10.2174\/1871526518666180803141827"},{"key":"3434_CR24","doi-asserted-by":"crossref","unstructured":"El-Awady E-SE, Moustafa YM, Abo-Elmatty DM, Radwan A (2011) Cisplatin-induced cardiotoxicity: mechanisms and cardioprotective strategies. European J Pharmacol 650(1):335\u201341","DOI":"10.1016\/j.ejphar.2010.09.085"},{"issue":"1\u20132","key":"3434_CR25","first-page":"95","volume":"61","author":"N Stilinovi\u0107","year":"2008","unstructured":"Stilinovi\u0107 N (2008) Influence of silymarin and doxorubicin on the myocardial function in rats. Med Pregl 61(1\u20132):95\u201398","journal-title":"Med Pregl"},{"issue":"S1","key":"3434_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/ptr.811","volume":"16","author":"J Psotov\u00e1","year":"2002","unstructured":"Psotov\u00e1 J, Chlop\u010d\u00edkov\u00e1 \u0160, Grambal F, \u0160im\u00e1nek V, Ulrichov\u00e1 J (2002) Influence of silymarin and its flavonolignans on doxorubicin-iron induced lipid peroxidation in rat heart microsomes and mitochondria in comparison with quercetin. Phytother Res 16(S1):63\u201367","journal-title":"Phytother Res"},{"key":"3434_CR27","doi-asserted-by":"crossref","unstructured":"Hagag AA, Elgamsy MA, El-Asy HM, Mabrouk MM (2016) Protective role of silymarin on hepatic and renal toxicity induced by MTX based chemotherapy in children with acute lymphoblastic leukemia. Mediterranean J Hematol Infect Dis 8(1)","DOI":"10.4084\/mjhid.2016.043"},{"key":"3434_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.taap.2017.04.023","volume":"327","author":"EM Assis-J\u00fanior","year":"2017","unstructured":"Assis-J\u00fanior EM, Melo AT, Pereira VBM, Wong DVT, Sousa NRP, Oliveira CMG et al (2017) Dual effect of silymarin on experimental non-alcoholic steatohepatitis induced by irinotecan. Toxicol Appl Pharmacol 327:71\u201379","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"3434_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.taap.2010.02.002","volume":"245","author":"N Patel","year":"2010","unstructured":"Patel N, Joseph C, Corcoran GB, Ray SD (2010) Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver. Toxicol Appl Pharmacol 245(2):143\u2013152","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"3434_CR30","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/toxres\/tfaa080","volume":"9","author":"NA Abbas","year":"2020","unstructured":"Abbas NA, Awad MM, Nafea OE (2020) Silymarin in combination with chlorogenic acid protects against hepatotoxicity induced by doxorubicin in rats: possible role of adenosine monophosphate\u2013activated protein kinase pathway. Toxicology Research 9(6):771\u2013777","journal-title":"Toxicology Research"},{"issue":"6","key":"3434_CR31","doi-asserted-by":"publisher","first-page":"656","DOI":"10.5483\/BMBRep.2006.39.6.656","volume":"39","author":"HH Mansour","year":"2006","unstructured":"Mansour HH, Hafez HF, Fahmy NM (2006) Silymarin modulates cisplatin-induced oxidative stress and hepatotoxicity in rats. BMB Rep 39(6):656\u2013661","journal-title":"BMB Rep"},{"issue":"3","key":"3434_CR32","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1177\/1078155212438252","volume":"18","author":"A McBride","year":"2012","unstructured":"McBride A, Augustin KM, Nobbe J, Westervelt P (2012) Silybum marianum (milk thistle) in the management and prevention of hepatotoxicity in a patient undergoing reinduction therapy for acute myelogenous leukemia. J Oncol Pharm Pract 18(3):360\u2013365","journal-title":"J Oncol Pharm Pract"},{"issue":"6","key":"3434_CR33","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1006\/phrs.2002.0990","volume":"45","author":"LA Ramadan","year":"2002","unstructured":"Ramadan LA, Roushdy HM, Senna GMA, Amin NE, El-Deshw OA (2002) Radioprotective effect of silymarin against radiation induced hepatotoxicity. Pharmacol Res 45(6):447\u2013454","journal-title":"Pharmacol Res"},{"issue":"10","key":"3434_CR34","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3923\/pjbs.2010.463.479","volume":"13","author":"N Abdelmeguid","year":"2010","unstructured":"Abdelmeguid N, Chmaisse H, Abou ZN (2010) Silymarin ameliorates cisplatin-induced hepatotoxicity in rats: histopathological and ultrastructural studies. Pakistan J Biol Sci PJBS 13(10):463\u2013479","journal-title":"Pakistan journal of biological sciences: PJBS"},{"issue":"2","key":"3434_CR35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00280-017-3358-x","volume":"80","author":"JCF Quintanilha","year":"2017","unstructured":"Quintanilha JCF, de Sousa VM, Visacri MB, Amaral LS, Santos RMM, Zambrano T et al (2017) Involvement of cytochrome P450 in cisplatin treatment: implications for toxicity. Cancer Chemother Pharmacol 80(2):223\u2013233","journal-title":"Cancer Chemother Pharmacol"},{"key":"3434_CR36","doi-asserted-by":"publisher","first-page":"8993","DOI":"10.14260\/jemds\/2015\/1305","volume":"4","author":"N Singh","year":"2015","unstructured":"Singh N, Magotra R, Sharma AK, Ahmed M, Khajuria V (2015) Effect of cisplatin on liver of male albino rats. J Evol Med Dent Sci 4:8993\u20138998","journal-title":"J Evol Med Dent Sci"},{"issue":"13","key":"3434_CR37","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1245\/s10434-012-2438-8","volume":"19","author":"SM Robinson","year":"2012","unstructured":"Robinson SM, Wilson CH, Burt AD, Manas DM, White SA (2012) Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis. Ann Surg Oncol 19(13):4287\u20134299","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"3434_CR38","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00280-014-2434-8","volume":"74","author":"MLV Costa","year":"2014","unstructured":"Costa MLV, Lima-J\u00fanior RCP, Arag\u00e3o KS, Medeiros RP, Marques-Neto RD, de S\u00e1 GL et al (2014) Chemotherapy-associated steatohepatitis induced by irinotecan: a novel animal model. Cancer Chemother Pharmacol 74(4):711\u2013720","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"3434_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.phrs.2003.12.013","volume":"50","author":"N \u0160kottov\u00e1","year":"2004","unstructured":"\u0160kottov\u00e1 N, Kazdov\u00e1 L, Oliyarnyk O, Ve\u010de\u0159a R, Sobolov\u00e1 L, Ulrichov\u00e1 J (2004) Phenolics-rich extracts from Silybum marianum and Prunella vulgaris reduce a high-sucrose diet induced oxidative stress in hereditary hypertriglyceridemic rats. Pharmacol Res 50(2):123\u2013130","journal-title":"Pharmacol Res"},{"issue":"10","key":"3434_CR40","first-page":"2697","volume":"12","author":"E Cecen","year":"2011","unstructured":"Cecen E, Dost T, Culhaci N, Karul A, Ergur B, Birincioglu M (2011) Protective effects of silymarin against doxorubicin-induced toxicity. Asian Pacific J Canc Prev APJCP 12(10):2697\u20132704","journal-title":"Asian Pacific journal of cancer prevention: APJCP"},{"issue":"9","key":"3434_CR41","first-page":"462","volume":"7","author":"EM Calegari","year":"2015","unstructured":"Calegari EM, Endres HC, Dallegrave E, Cendron L, Bertol C, Siqueira L et al (2015) Silymarin elicits partial protection against methotrexate-induced hepatotoxicity in wistar rats. Int J Pharm Pharm Sci 7(9):462\u2013465","journal-title":"Int J Pharm Pharm Sci"},{"issue":"6","key":"3434_CR42","first-page":"464","volume":"11","author":"AR Ghaffari","year":"2011","unstructured":"Ghaffari AR, Noshad H, Ostadi A, Ghojazadeh M, Asadi P (2011) The effects of milk thistle on hepatic fibrosis due to methotrexate in rat. Hepat Mon 11(6):464","journal-title":"Hepat Mon"},{"key":"3434_CR43","doi-asserted-by":"crossref","unstructured":"Ladas EJ, Kroll DJ, Oberlies NH, Cheng B, Ndao DH, Rheingold SR et al (2010)\u00a0A randomized, controlled, double\u2010blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL). Cancer: Interdisciplin Inter J Am Canc Soc 116(2):506\u201313","DOI":"10.1002\/cncr.24723"},{"key":"3434_CR44","doi-asserted-by":"crossref","unstructured":"Ghazizadeh F, Noroozi M, Shadara P, Rasouli J, Hejazi S (2021) New therapy for chemotherapy-induced hepatic failure in leukemia; a randomized double-blind clinical trial study","DOI":"10.34172\/ipp.2021.16"},{"key":"3434_CR45","unstructured":"Emami H, Shakeri AA, Akhavan A, Shahbazi-Gahrouei D, Akbari P (2018) Effect of livergol on the improvement of fatty liver in patients with cancer undergoing irinotecan-and oxaliplatin-based chemotherapy regimen. Journal of Research in Medical Sciences: The Offic J Isfahan Univ Med Sci 23."},{"key":"3434_CR46","doi-asserted-by":"crossref","unstructured":"Mshemish BAR, Al-Khazragy KA, AL-Nakaash MAI, Fatah WA (2011) Effect of silymarin against CAF protocol hepatotoxicity. Al-Mustansiriyah Journal of Pharmaceutical Sciences (AJPS) 9(1):52\u201362","DOI":"10.32947\/ajps.v9i1.271"},{"issue":"6","key":"3434_CR47","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.eujim.2015.10.012","volume":"7","author":"F Mohaghegh","year":"2015","unstructured":"Mohaghegh F, Solhi H, Kazemifar AM (2015) Silymarin (milk thistle) can revoke liver enzyme changes during chemotherapy of breast cancer with Taxanes. European J Integrat Med 7(6):650\u2013652","journal-title":"European Journal of Integrative Medicine"},{"key":"3434_CR48","doi-asserted-by":"crossref","unstructured":"Moezian GSA, Javadinia SA, Sales SS, Fanipakdel A, Elyasi S, Karimi G (2021) Oral silymarin formulation efficacy in management of AC-T protocol induced hepatotoxicity in breast cancer patients: a randomized, triple blind, placebo-controlled clinical trial. J Oncol Pharm Pract 10781552211006182","DOI":"10.1177\/10781552211006182"},{"issue":"8","key":"3434_CR49","first-page":"4323","volume":"34","author":"J Bosch-Barrera","year":"2014","unstructured":"Bosch-Barrera J, Corominas-Faja B, Cuyas E, Martin-Castillo B, Brunet J, Menendez JA (2014) Silibinin administration improves hepatic failure due to extensive liver infiltration in a breast cancer patient. Anticancer Res 34(8):4323\u20134327","journal-title":"Anticancer Res"},{"issue":"5","key":"3434_CR50","first-page":"340","volume":"78","author":"R Ivernizzi","year":"1993","unstructured":"Ivernizzi R, Bernuzzi S, Ciani D, Ascari E (1993) Silymarine during maintenance therapy of acute promyelocytic leukemia. Haematologica 78(5):340\u2013341","journal-title":"Haematologica"},{"issue":"2","key":"3434_CR51","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1177\/10781552211052564","volume":"28","author":"R Sakran","year":"2022","unstructured":"Sakran R, Milo G, Jabareen A, Artul T, Haim N, Litvak M et al (2022) Effective elimination of high-dose methotrexate by repeated hemodiafiltration and high-flux hemodialysis in patients with acute kidney injury. J Oncol Pharm Pract 28(2):508\u2013515","journal-title":"J Oncol Pharm Pract"},{"issue":"3","key":"3434_CR52","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/ecam\/neh103","volume":"2","author":"G Karimi","year":"2005","unstructured":"Karimi G, Ramezani M, Tahoonian Z (2005) Cisplatin nephrotoxicity and protection by milk thistle extract in rats. Evidence-Based Complementary and Alternative Medicine 2(3):383\u2013386","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"key":"3434_CR53","doi-asserted-by":"crossref","unstructured":"Ibrahim ME-T, El Bana E, El-Kerdasy HI (2018) Role of bone marrow derived mesenchymal stem cells and the protective effect of silymarin in cisplatin-induced acute renal failure in rats. The Am J Med Sci 355(1):76\u201383","DOI":"10.1016\/j.amjms.2017.08.004"},{"issue":"12","key":"3434_CR54","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1038\/bjc.1996.673","volume":"74","author":"C Bokemeyer","year":"1996","unstructured":"Bokemeyer C, Fels L, Dunn T, Voigt W, Gaedeke J, Schmoll H et al (1996) Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity. Br J Cancer 74(12):2036\u20132041","journal-title":"Br J Cancer"},{"issue":"10","key":"3434_CR55","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3109\/13880209.2011.568506","volume":"49","author":"C Ninsontia","year":"2011","unstructured":"Ninsontia C, Pongjit K, Chaotham C, Chanvorachote P (2011) Silymarin selectively protects human renal cells from cisplatin-induced cell death. Pharm Biol 49(10):1082\u20131090","journal-title":"Pharm Biol"},{"issue":"7","key":"3434_CR56","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/ptr.5345","volume":"29","author":"F Shahbazi","year":"2015","unstructured":"Shahbazi F, Sadighi S, Dashti-Khavidaki S, Shahi F, Mirzania M, Abdollahi A et al (2015) Effect of silymarin administration on cisplatin nephrotoxicity: report from a pilot, randomized, double-blinded, placebo-controlled clinical trial. Phytother Res 29(7):1046\u20131053","journal-title":"Phytother Res"},{"issue":"4","key":"3434_CR57","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s10735-022-10089-3","volume":"53","author":"F Yang","year":"2022","unstructured":"Yang F, Jia M, Deng C, Xiao B, Dai R, Xiang Y (2022) Silibinin ameliorates cisplatin-induced acute kidney injury via activating nfe2l1-mediated antioxidative response to suppress the ros\/mapk signaling pathway. J Mol Histol 53(4):729\u2013740","journal-title":"J Mol Histol"},{"issue":"4","key":"3434_CR58","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3109\/0886022X.2015.1012984","volume":"37","author":"DO Dabak","year":"2015","unstructured":"Dabak DO, Kocaman N (2015) Effects of silymarin on methotrexate-induced nephrotoxicity in rats. Ren Fail 37(4):734\u2013739","journal-title":"Ren Fail"},{"issue":"7","key":"3434_CR59","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.fct.2008.03.033","volume":"46","author":"NA El-Shitany","year":"2008","unstructured":"El-Shitany NA, El-Haggar S, El-Desoky K (2008) Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats. Food Chem Toxicol 46(7):2422\u20132428","journal-title":"Food Chem Toxicol"},{"key":"3434_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2019.104299","volume":"111","author":"N Abdel-Magied","year":"2019","unstructured":"Abdel-Magied N, Elkady AA (2019) Possible curative role of curcumin and silymarin against nephrotoxicity induced by gamma-rays in rats. Exp Mol Pathol 111:104299","journal-title":"Exp Mol Pathol"},{"issue":"8","key":"3434_CR61","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1080\/10837450.2018.1556690","volume":"24","author":"S Soodvilai","year":"2019","unstructured":"Soodvilai S, Tipparos W, Rangsimawong W, Patrojanasophon P, Soodvilai S, Sajomsang W et al (2019) Effects of silymarin-loaded amphiphilic chitosan polymeric micelles on the renal toxicity and anticancer activity of cisplatin. Pharm Dev Technol 24(8):927\u2013934","journal-title":"Pharm Dev Technol"},{"key":"3434_CR62","unstructured":"Momeni A, Hajigholami A, Geshnizjani S, Kheiri S (20105) Effect of silymarin in the prevention of cisplatin nephrotoxicity, a clinical trial study. Journal of clinical and diagnostic research: JCDR 9(4):OC11"},{"issue":"3","key":"3434_CR63","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ijporl.2013.12.024","volume":"78","author":"SI Cho","year":"2014","unstructured":"Cho SI, Lee J-E, Do NY (2014) Protective effect of silymarin against cisplatin-induced ototoxicity. Int J Pediatr Otorhinolaryngol 78(3):474\u2013478","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"9","key":"3434_CR64","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/jphp.12745","volume":"69","author":"S-K Shafiei-Roudbari","year":"2017","unstructured":"Shafiei-Roudbari S-K, Malekinejad H, Janbaz-Aciabar H, Razi M (2017) Crosstalk between E2F1 and P53 transcription factors in doxorubicin-induced DNA damage: evidence for preventive\/protective effects of silymarin. J Pharm Pharmacol 69(9):1116\u20131124","journal-title":"J Pharm Pharmacol"},{"issue":"12","key":"3434_CR65","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.phymed.2012.06.011","volume":"19","author":"H Malekinejad","year":"2012","unstructured":"Malekinejad H, Janbaz-Acyabar H, Razi M, Varasteh S (2012) Preventive and protective effects of silymarin on doxorubicin-induced testicular damages correlate with changes in c-myc gene expression. Phytomedicine 19(12):1077\u20131084","journal-title":"Phytomedicine"},{"key":"3434_CR66","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejphar.2014.02.010","volume":"730","author":"HG Oufi","year":"2014","unstructured":"Oufi HG, Al-Shawi NN (2014) The effects of different doses of silibinin in combination with methotrexate on testicular tissue of mice. Eur J Pharmacol 730:36\u201340","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"3434_CR67","doi-asserted-by":"publisher","first-page":"4524","DOI":"10.19082\/4524","volume":"9","author":"M Marzban","year":"2017","unstructured":"Marzban M, Anjamshoa M, Jafari P, Masoumi H, Ahadi R, Fatehi D (2017) Effects of gamma rays on rat testis tissue according to the morphological parameters and immunohistochemistry: radioprotective role of silymarin. Electron Physician 9(6):4524","journal-title":"Electron Physician"},{"key":"3434_CR68","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jphotobiol.2017.12.004","volume":"178","author":"D Fatehi","year":"2018","unstructured":"Fatehi D, Mohammadi M, Shekarchi B, Shabani A, Seify M, Rostamzadeh A (2018) Radioprotective effects of silymarin on the sperm parameters of NMRI mice irradiated with \u03b3-rays. J Photochem Photobiol, B 178:489\u2013495","journal-title":"J Photochem Photobiol, B"},{"issue":"6","key":"3434_CR69","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.3390\/nu12061675","volume":"12","author":"PM Anderson","year":"2020","unstructured":"Anderson PM, Lalla RV (2020) Glutamine for amelioration of radiation and chemotherapy associated mucositis during cancer therapy. Nutrients 12(6):1675","journal-title":"Nutrients"},{"issue":"4","key":"3434_CR70","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/1534735418794885","volume":"17","author":"M Thomsen","year":"2018","unstructured":"Thomsen M, Vitetta L (2018) Adjunctive treatments for the prevention of chemotherapy-and radiotherapy-induced mucositis. Integr Cancer Ther 17(4):1027\u20131047","journal-title":"Integr Cancer Ther"},{"issue":"11","key":"3434_CR71","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/ptr.5704","volume":"30","author":"S Elyasi","year":"2016","unstructured":"Elyasi S, Hosseini S, Niazi Moghadam MR, Aledavood SA, Karimi G (2016) Effect of oral silymarin administration on prevention of radiotherapy induced mucositis: a randomized, double-blinded, placebo-controlled clinical trial. Phytother Res 30(11):1879\u20131885","journal-title":"Phytother Res"},{"issue":"4","key":"3434_CR72","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3109\/01480545.2014.992072","volume":"38","author":"A Sasu","year":"2015","unstructured":"Sasu A, Herman H, Mariasiu T, Rosu M, Balta C, Anghel N et al (2015) Protective effects of silymarin on epirubicin-induced mucosal barrier injury of the gastrointestinal tract. Drug Chem Toxicol 38(4):442\u2013451","journal-title":"Drug Chem Toxicol"},{"key":"3434_CR73","doi-asserted-by":"crossref","unstructured":"Altaei T (2012) Treatment of chemotherapy-induced oral mucositis by silymarin. Annals of Oncology 23:ix163","DOI":"10.1016\/S0923-7534(20)33033-7"},{"key":"3434_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.phanu.2021.100253","volume":"15","author":"S Hosseini","year":"2021","unstructured":"Hosseini S, Rezaei S, Moghaddam MRN, Elyasi S, Karimi G (2021) Evaluation of oral nano-silymarin formulation efficacy on prevention of radiotherapy induced mucositis: a randomized, double-blinded, placebo-controlled clinical trial. PharmaNutrition 15:100253","journal-title":"PharmaNutrition"},{"issue":"6","key":"3434_CR75","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1097\/01.ju.0000085593.31396.d8","volume":"170","author":"A Korkmaz","year":"2003","unstructured":"Korkmaz A, Oter S, Deveci S, Ozgurtas T, Topal T, Sadir S et al (2003) Involvement of nitric oxide and hyperbaric oxygen in the pathogenesis of cyclophosphamide induced hemorrhagic cystitis in rats. J Urol 170(6):2498\u20132502","journal-title":"J Urol"},{"issue":"8\u20139","key":"3434_CR76","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.phymed.2012.04.006","volume":"19","author":"N Eser","year":"2012","unstructured":"Eser N, G\u00f6\u00e7men C, Erdo\u011fan \u015e, B\u00fcy\u00fcknacar HSG, Kumcu EK, A\u00e7\u0131kal\u0131n A et al (2012) Effect of silymarin on bladder overactivity in cyclophosphamide-induced cystitis rat model. Phytomedicine 19(8\u20139):840\u2013845","journal-title":"Phytomedicine"},{"key":"3434_CR77","unstructured":"AGCNS-BC CBMA, Maloney C, ELS MVMA editors (2020) Radiodermatitis in patients with cancer: systematic review and meta-analysis. Oncology Nursing Forum\u00a0Oncology Nursing Society"},{"key":"3434_CR78","doi-asserted-by":"crossref","unstructured":"Wickline MM editor (2004) Prevention and treatment of acute radiation dermatitis: a literature review. Oncol Nurs Forum\u00a031(2):237\u2013247","DOI":"10.1188\/04.ONF.237-247"},{"issue":"8","key":"3434_CR79","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00066-011-2204-z","volume":"187","author":"M Becker-Schiebe","year":"2011","unstructured":"Becker-Schiebe M, Mengs U, Schaefer M, Bulitta M, Hoffmann W (2011) Topical use of a silymarin-based preparation to prevent radiodermatitis. Strahlenther Onkol 187(8):485\u2013491","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"3434_CR80","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4103\/ijp.ijp_175_21","volume":"54","author":"A Zaiem","year":"2022","unstructured":"Zaiem A, Hammamia SB, Aouinti I, Charfi O, Ladhari W, Kastalli S et al (2022) Hand\u2013foot syndrome induced by chemotherapy drug: case series study and literature review. Indian Journal of Pharmacology 54(3):208","journal-title":"Indian Journal of Pharmacology"},{"issue":"10","key":"3434_CR81","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1021\/acs.chemrestox.6b00215","volume":"29","author":"Y Lou","year":"2016","unstructured":"Lou Y, Wang Q, Zheng J, Hu H, Liu L, Hong D et al (2016) Possible pathways of capecitabine-induced hand\u2013foot syndrome. Chem Res Toxicol 29(10):1591\u20131601","journal-title":"Chem Res Toxicol"},{"key":"3434_CR82","doi-asserted-by":"crossref","unstructured":"Hung C-F, Lin Y-K, Zhang L-W, Chang C-H, Fang J-Y (2010) Topical delivery of silymarin constituents via the skin route. Acta Pharmacologica Sinica 31(1):118\u201326","DOI":"10.1038\/aps.2009.186"},{"key":"3434_CR83","doi-asserted-by":"crossref","unstructured":"Kwakman JJ, Elshot YS, Punt CJ, Koopman M (2020) Management of cytotoxic chemotherapy-induced hand-foot syndrome. Oncol Rev 14(1)","DOI":"10.4081\/oncol.2020.442"},{"issue":"6","key":"3434_CR84","first-page":"1585","volume":"22","author":"LT Macedo","year":"2014","unstructured":"Macedo LT, Lima JPN, dos Santos LV, Sasse AD (2014) Prevention strategies for chemotherapy-induced hand\u2013foot syndrome: a systematic review and meta-analysis of prospective randomised trials. Support Care Cancer 22(6):1585\u20131593","journal-title":"Support Care Cancer"},{"issue":"4","key":"3434_CR85","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jaad.2014.03.019","volume":"71","author":"KK Miller","year":"2014","unstructured":"Miller KK, Gorcey L, McLellan BN (2014) Chemotherapy-induced hand-foot syndrome and nail changes: a review of clinical presentation, etiology, pathogenesis, and management. J Am Acad Dermatol 71(4):787\u2013794","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"3434_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-022-06353-2","volume":"23","author":"A Santhosh","year":"2022","unstructured":"Santhosh A, Kumar A, Pramanik R, Gogia A, Prasad CP, Gupta I et al (2022) Randomized double-blind, placebo-controlled study of topical diclofenac in the prevention of hand-foot syndrome in patients receiving capecitabine (the D-TORCH study). Trials 23(1):1\u201310","journal-title":"Trials"},{"issue":"3","key":"3434_CR87","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/ced.12538","volume":"40","author":"S Jo","year":"2015","unstructured":"Jo S, Shin H, Jo S, Kwon O, Myung SK (2015) Prophylactic and therapeutic efficacy of pyridoxine supplements in the management of hand\u2013foot syndrome during chemotherapy: a meta-analysis. Clin Exp Dermatol 40(3):260\u2013270","journal-title":"Clin Exp Dermatol"},{"key":"3434_CR88","doi-asserted-by":"crossref","unstructured":"Kao YS, Lo CH, Tu YK, Hung CH (2022) Pharmacological prevention strategy for capecitabine\u2010induced hand\u2010foot syndrome: a network meta\u2010analysis of randomized control trials. Dermatologic Therapy e15774","DOI":"10.1111\/dth.15774"},{"issue":"10","key":"3434_CR89","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3109\/13880209.2014.889176","volume":"52","author":"K Razavi-Azarkhiavi","year":"2014","unstructured":"Razavi-Azarkhiavi K, Ali-Omrani M, Solgi R, Bagheri P, Haji-Noormohammadi M, Amani N et al (2014) Silymarin alleviates bleomycin-induced pulmonary toxicity and lipid peroxidation in mice. Pharm Biol 52(10):1267\u20131271","journal-title":"Pharm Biol"},{"key":"3434_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.145239","volume":"769","author":"A Yard\u0131m","year":"2021","unstructured":"Yard\u0131m A, Kucukler S, \u00d6zdemir S, \u00c7omakl\u0131 S, Caglayan C, Kandemir FM et al (2021) Silymarin alleviates docetaxel-induced central and peripheral neurotoxicity by reducing oxidative stress, inflammation and apoptosis in rats. Gene 769:145239","journal-title":"Gene"},{"key":"3434_CR91","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jff.2018.11.044","volume":"52","author":"L Zhao","year":"2019","unstructured":"Zhao L, Yang H, Xu M, Wang X, Wang C, Lian Y et al (2019) Stevia residue extract ameliorates oxidative stress in d-galactose-induced aging mice via Akt\/Nrf2\/HO-1 pathway. Journal of Functional Foods 52:587\u2013595","journal-title":"Journal of Functional Foods"},{"issue":"4","key":"3434_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062101","volume":"8","author":"CA Mayer","year":"2013","unstructured":"Mayer CA, Brunkhorst R, Niessner M, Pfeilschifter W, Steinmetz H, Foerch C (2013) Blood levels of glial fibrillary acidic protein (GFAP) in patients with neurological diseases. PLoS ONE 8(4):e62101","journal-title":"PLoS ONE"},{"issue":"4","key":"3434_CR93","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1007\/s11481-016-9694-5","volume":"11","author":"R Klein","year":"2016","unstructured":"Klein R, Mahlberg N, Ohren M, Ladwig A, Neumaier B, Graf R et al (2016) The neural cell adhesion molecule-derived (NCAM)-peptide FG loop (FGL) mobilizes endogenous neural stem cells and promotes endogenous regenerative capacity after stroke. J Neuroimmune Pharmacol 11(4):708\u2013720","journal-title":"J Neuroimmune Pharmacol"},{"key":"3434_CR94","doi-asserted-by":"crossref","unstructured":"Mannelli LDC, Zanardelli M, Failli P, Ghelardini C (2012) Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin. The J Pain 13(3):276\u201384","DOI":"10.1016\/j.jpain.2011.11.009"},{"key":"3434_CR95","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.freeradbiomed.2013.03.019","volume":"61","author":"LDC Mannelli","year":"2013","unstructured":"Mannelli LDC, Zanardelli M, Failli P, Ghelardini C (2013) Oxaliplatin-induced oxidative stress in nervous system-derived cellular models: could it correlate with in vivo neuropathy? Free Radical Biol Med 61:143\u2013150","journal-title":"Free Radical Biol Med"},{"issue":"78","key":"3434_CR96","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3727\/096504021X16218531628569","volume":"28","author":"T-K Chang","year":"2021","unstructured":"Chang T-K, Yin T-C, Su W-C, Tsai H-L, Huang C-W, Chen Y-C et al (2021) A pilot study of silymarin as supplementation to reduce toxicities in metastatic colorectal cancer patients treated with first-line FOLFIRI plus bevacizumab. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 28(78):801\u2013809","journal-title":"Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics"},{"issue":"7","key":"3434_CR97","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2174\/1389450111314070007","volume":"14","author":"U Swami","year":"2013","unstructured":"Swami U, Goel S, Mani S (2013) Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis. Curr Drug Targets 14(7):777\u2013797","journal-title":"Curr Drug Targets"},{"key":"3434_CR98","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.phrs.2018.10.029","volume":"139","author":"K-W Cheng","year":"2019","unstructured":"Cheng K-W, Tseng C-H, Tzeng C-C, Leu Y-L, Cheng T-C, Wang J-Y et al (2019) Pharmacological inhibition of bacterial \u03b2-glucuronidase prevents irinotecan-induced diarrhea without impairing its antitumor efficacy in vivo. Pharmacol Res 139:41\u201349","journal-title":"Pharmacol Res"},{"issue":"6","key":"3434_CR99","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/ptr.6361","volume":"33","author":"V Soleimani","year":"2019","unstructured":"Soleimani V, Delghandi PS, Moallem SA, Karimi G (2019) Safety and toxicity of silymarin, the major constituent of milk thistle extract: an updated review. Phytother Res 33(6):1627\u20131638","journal-title":"Phytother Res"},{"key":"3434_CR100","unstructured":"Albrecht M (1992) Therapy of toxic liver pathologies with Legalon"},{"issue":"20","key":"3434_CR101","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.3390\/molecules24203693","volume":"24","author":"Y Xie","year":"2019","unstructured":"Xie Y, Zhang D, Zhang J, Yuan J (2019) Metabolism, transport and drug\u2013drug interactions of silymarin. Molecules 24(20):3693","journal-title":"Molecules"},{"key":"3434_CR102","doi-asserted-by":"crossref","unstructured":"Afsar T, Razak S, Almajwal A. Effect of Acacia hydaspica R (2019) Parker extract on lipid peroxidation, antioxidant status, liver function test and histopathology in doxorubicin treated rats. Lip Health Dis 18(1):1\u201312","DOI":"10.1186\/s12944-019-1051-2"},{"key":"3434_CR103","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2147\/IJN.S187888","volume":"14","author":"Y Li","year":"2019","unstructured":"Li Y, Yang D, Wang Y, Li Z, Zhu C (2019) Co-delivery doxorubicin and silybin for anti-hepatoma via enhanced oral hepatic-targeted efficiency. Int J Nanomed 14:301","journal-title":"Int J Nanomed"},{"key":"3434_CR104","first-page":"178","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, Ye Z, Lai W, Rao J, Huang W, Zhang X et al (2017) Activation of sirtuin 3 by silybin attenuates mitochondrial dysfunction in cisplatin-induced acute kidney injury. Front Pharmacol 8:178","journal-title":"Front Pharmacol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-022-03434-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-022-03434-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-022-03434-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T19:39:49Z","timestamp":1728502789000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-022-03434-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":104,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["3434"],"URL":"https:\/\/doi.org\/10.1007\/s00228-022-03434-8","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"assertion":[{"value":"30 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}